uk biobank |
11 |
mendelian randomization |
10 |
coronary heart disease |
8 |
genetic susceptibility |
7 |
adolescents |
6 |
drug-target mendelian randomization |
6 |
genetic risk |
6 |
hmgcr inhibitors |
6 |
metformin |
6 |
pcsk9 inhibitors |
6 |
safety |
6 |
alzheimer’s disease |
5 |
dementia |
5 |
hypertension |
5 |
mendelian randomisation |
5 |
mendelian randomization analysis |
5 |
active transport |
4 |
ampk |
4 |
cancer |
4 |
coronary artery disease |
4 |
covid-19 |
4 |
metformin targets |
4 |
abdominal obesity |
3 |
ace2 |
3 |
blood pressure |
3 |
cardiometabolic risk markers |
3 |
cardiovascular disease |
3 |
cardiovascular risk factor |
3 |
causal inference |
3 |
computer use |
3 |
disease aetiology |
3 |
ferritin |
3 |
fgf23 |
3 |
genetic epidemiology |
3 |
genetics |
3 |
glycaemic traits |
3 |
glycated hemoglobin |
3 |
grip strength |
3 |
growth differentiation factor 15 |
3 |
hba1c |
3 |
healthy lifestyle |
3 |
hemoglobin |
3 |
hepcidin |
3 |
iron |
3 |
kidney disease |
3 |
lifestyle |
3 |
linearity |
3 |
longevity |
3 |
mediation |
3 |
mendelian randomization studies |
3 |
older adults |
3 |
physical activity |
3 |
polygenic risk scores |
3 |
random allocation |
3 |
randomization mr |
3 |
sedentary behavior |
3 |
sex hormones |
3 |
stroke |
3 |
systematic review |
3 |
testosterone |
3 |
tv viewing |
3 |
type 2 diabetes |
3 |
type 2 diabetes mellitus |
3 |
venous thromboembolism |
3 |
adamts-13 |
2 |
brain expression |
2 |
cardiometabolic diseases |
2 |
chronic diseases |
2 |
cognitive function |
2 |
diabetes mellitus |
2 |
general population |
2 |
ischemic heart disease |
2 |
lipids |
2 |
liver - physiology - china - guangzhou |
2 |
mitochondrial function |
2 |
non-diabetic individuals |
2 |
smoking - china - guangzhou |
2 |